Figure 2 | Scientific Reports

Figure 2

From: Effect of silibinin capsules combined with lifestyle modification on hepatic steatosis in patients with chronic hepatitis B

Figure 2

(a) Change in the CAP value from 0 to 24 weeks in the SC combined with TLC and TLC alone groups. (b) Distribution of percentages of patients with different degrees of hepatic steatosis at baseline and at the end of intervention in the SC combined with TLC and TLC alone groups, as assessed by the CAP measurement using TE. (c,d) Change in the CAP value of patients with different steatosis grades (S1, S2, and S3) from 0 to 24 weeks in the SC combined with TLC and TLC alone group.

Back to article page